BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Pharm Country

  BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

  BioReference® Health LLC announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from Roche Diagnostics.

  February 9, 2023

   · 

  3 min read
• Bio NC

  Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea

  Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development business will be known as Fortrea.

  February 9, 2023

   · 

  7 min read
• Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

  Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding.

  February 9, 2023

   · 

  4 min read
• Genetown

  Aura Biosciences to Participate in Upcoming Investor Conferences - February 9, 2023

  Aura Biosciences Inc. today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences.

  February 9, 2023

   · 

  2 min read
• Genetown

  AVROBIO to Present Clinical and Preclinical Data from Lysosomal Disorder Gene Therapy Pipeline at WORLDSymposium™ 2023

  AVROBIO to Present Clinical and Preclinical Data from Lysosomal Disorder Gene Therapy Pipeline at WORLD Symposium ™ 2023.

  February 9, 2023

   · 

  7 min read
• Business

  Baxter Reports Fourth-Quarter and Full-Year 2022 Results

  Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023.

  February 9, 2023

   · 

  50 min read
• Pharm Country

  Oramed Pharmaceuticals Issues Shareholder Update - February 09, 2023

  Oramed Pharmaceuticals Inc., announced that it continues to conduct a comprehensive analysis of the data from its discontinued Phase 3 oral insulin trials.

  February 9, 2023

   · 

  4 min read
• NewAmsterdam Pharma to Present at the SVB Securities Global BioPharma Conference

  NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam Pharma” or the “Company”) today announced that Michael Davidson, M.D., chief executive officer of NewAmsterdam Pharma, will present at SVB Securities Global Biopharma Conference on Thursday, February 16, 2023 at 1:00 p.m. ET.

  February 9, 2023

   · 

  2 min read
• Business

  AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results

  AbbVie (NYSE:ABBV) announced financial results for the fourth quarter and full year ended December 31, 2022.

  February 9, 2023

   · 

  27 min read
• Drug Development

  Cognition Therapeutics Completes Enrollment of CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s DiseaseInnovative Trial Explores Theta Wave qEEG as a Biomarker of Synaptic Dysfunction

  Cognition Therapeutics, Inc. (Nasdaq: CGTX) today announced that enrollment has completed in the randomized, double-blind Phase 2 SEQUEL study (COG0202, NCT04735536) of CT1812 in 16 adults with mild-to-moderate Alzheimer’s disease.

  February 9, 2023

   · 

  7 min read